Lars Eric Sundstrom
Keine laufenden Positionen mehr
Profil
Dr. Lars E.
Sundstrom is Chief Scientific Officer at Capsant Neurotechnologies Ltd.
Dr. Sundstrom was previously employed as a Principal by University of Bordeaux, a Principal by University of Geneva, and a Professor by The University of Southampton.
He also served on the board at The University of Southampton.
He received his undergraduate degree from the University of Oxford.
Ehemalige bekannte Positionen von Lars Eric Sundstrom
| Unternehmen | Position | Ende |
|---|---|---|
Capsant Neurotechnologies Ltd.
 Capsant Neurotechnologies Ltd. Pharmaceuticals: MajorHealth Technology Capsant Neurotechnologies Ltd. provided pre-clinical assay services to the drug development industry. It offered in-vitro tissue based screening technologies based on ex-vivo tissues and reaggregated 3D systems. The firm significantly reduced the costs associated with pre-clinical drug development and shortening the overall decision process in the selection of lead candidates for clinical evaluation. The company was founded by Lars Eric Sundstrom, Ashley Ker Pringle and John Edward Chad on June 21, 2002 and was headquartered in Gray's Inn, the United Kingdom. | Gründer | - |
| Université de Bordeaux | Corporate Officer/Principal | - |
| The University of Southampton | Corporate Officer/Principal | - |
| University of Geneva | Corporate Officer/Principal | - |
| The University of Southampton | Direktor/Vorstandsmitglied | - |
Ausbildung von Lars Eric Sundstrom
| University of Oxford | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Capsant Neurotechnologies Ltd.
Capsant Neurotechnologies Ltd. Pharmaceuticals: MajorHealth Technology Capsant Neurotechnologies Ltd. provided pre-clinical assay services to the drug development industry. It offered in-vitro tissue based screening technologies based on ex-vivo tissues and reaggregated 3D systems. The firm significantly reduced the costs associated with pre-clinical drug development and shortening the overall decision process in the selection of lead candidates for clinical evaluation. The company was founded by Lars Eric Sundstrom, Ashley Ker Pringle and John Edward Chad on June 21, 2002 and was headquartered in Gray's Inn, the United Kingdom. | Health Technology |
